help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitchell, J.
Right arrow Articles by Goltzman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchell, J.
Right arrow Articles by Goltzman, D.

Journal of Clinical Endocrinology & Metabolism, Vol 61, 328-334, Copyright © 1985 by Endocrine Society

ARTICLES

Examination of circulating parathyroid hormone in pseudohypoparathyroidism

J Mitchell and D Goltzman

We examined characteristics of circulating PTH in three patients with pseudohypoparathyroidism type I. All patients were normocalcemic while receiving vitamin D therapy at the time of study. In all three, immunoreactive PTH levels were elevated, whereas bioactive levels were low or low normal. Analysis of plasma immunoreactivity by high performance liquid chromatography revealed a relative increase in hydrophobic moieties compared to patterns in patients with other hyperparathyroid states. Plasma or serum from these patients inhibited the stimulatory action of exogenous bovine PTH in an in vitro renal cytochemical bioassay and an in vitro renal adenylate cyclase assay. Such inhibition persisted after partial reduction, in one patient, of circulating immunoreactive PTH levels by an acute calcium challenge. Patient plasma did not bind bioactive 125I-labeled PTH in vitro. The results demonstrate abnormal persistence of elevated immunoreactive PTH levels in normocalcemic patients with pseudohypoparathyroidism, indicate that this circulating hormone may be altered, and suggest that a defect in PTH release and/or metabolism may accompany the other biochemical abnormalities known to occur in this disorder.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
S. M. Jan de Beur, C.-L. Ding, M. C. LaBuda, T. B. Usdin, and M. A. Levine
Pseudohypoparathyroidism 1b: Exclusion of Parathyroid Hormone and Its Receptors as Candidate Disease Genes
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2239 - 2246.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. D. Bettoun, M. Minagawa, M. Y. Kwan, H. S. Lee, T. Yasuda, G. N. Hendy, D. Goltzman, and J. H. White
Cloning and Characterization of the Promoter Regions of the Human Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene: Analysis of Deoxyribonucleic Acid from Normal Subjects and Patients with Pseudohypoparathyroidism Type 1b
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1031 - 1040.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society